Skip to main content
Top
Published in: Infection 5/2020

01-10-2020 | Ampicillin | Case Report

Abiotrophia defectiva as a cause of infective endocarditis with embolic complications in children

Authors: Seung Ha Song, Bin Ahn, Eun Hwa Choi, Seung-Pyo Lee, Eun Young Cho, Eun Jung Bae, Sang Yun Lee, Mi Kyoung Song, Woong Han Kim, Geena Kim, Taek Soo Kim, Mi Seon Han

Published in: Infection | Issue 5/2020

Login to get access

Abstract

Abiotrophia defectiva is a rare pathogen of infective endocarditis (IE) but is frequently involved in embolic complication and valvular dysfunction. IE caused by A. defectiva in children is poorly studied. This study reports four cases of A. defectiva IE in children and reviews previously reported five pediatric cases of A. defectiva IE. Most of the patients presented with a subacute course, with prolonged fever or atypical symptoms. Eight patients had embolic complications at presentation. All nine children were treated with combination antimicrobial therapy and six of them received surgical intervention. All patients recovered well without relapse. A. defectiva should be considered in children with infective endocarditis, especially in those with atypical presentations. As complications are frequent and more than half of the patients need surgical treatment, prompt diagnosis along with appropriate treatment is necessary.
Literature
1.
go back to reference Bouvet A. Human endocarditis due to nutritionally variant streptococci: Streptococcus adjacens and Streptococcus defectivus. Eur Heart J. 1995;16:24–7.CrossRef Bouvet A. Human endocarditis due to nutritionally variant streptococci: Streptococcus adjacens and Streptococcus defectivus. Eur Heart J. 1995;16:24–7.CrossRef
2.
go back to reference Alberti MO, Hindler JA, Humphries RM. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. Antimicrob Agents Chemother. 2015;60:1411–20.CrossRef Alberti MO, Hindler JA, Humphries RM. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. Antimicrob Agents Chemother. 2015;60:1411–20.CrossRef
3.
go back to reference Kawamura Y, Hou XG, Sultana F, Liu S, Yamamoto H, Ezaki T. Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. Nov. and Abiotrophia defectiva comb. nov., respectively. Int J Syst Bacteriol. 1995;45:798–803.PubMed Kawamura Y, Hou XG, Sultana F, Liu S, Yamamoto H, Ezaki T. Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. Nov. and Abiotrophia defectiva comb. nov., respectively. Int J Syst Bacteriol. 1995;45:798–803.PubMed
5.
go back to reference Christensen JJ, Facklam RR. Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol. 2001;39:3520–3.PubMedPubMedCentral Christensen JJ, Facklam RR. Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol. 2001;39:3520–3.PubMedPubMedCentral
6.
go back to reference Tellez A, Ambrosioni J, Llopis J, Pericàs JM, Falces C, Almela M, Garcia de la Mària C, Hernandez-Meneses M, Vidal B, Sandoval E, Quintana E, Fuster D, Tolosana JM, Marco F, Moreno A, Miro JM. Epidemiology, clinical features, and outcome of infective endocarditis due to Abiotrophia species and Granulicatella species: report of 76 cases, 2000–2015. Clin Infect Dis. 2018;66:104–11.PubMed Tellez A, Ambrosioni J, Llopis J, Pericàs JM, Falces C, Almela M, Garcia de la Mària C, Hernandez-Meneses M, Vidal B, Sandoval E, Quintana E, Fuster D, Tolosana JM, Marco F, Moreno A, Miro JM. Epidemiology, clinical features, and outcome of infective endocarditis due to Abiotrophia species and Granulicatella species: report of 76 cases, 2000–2015. Clin Infect Dis. 2018;66:104–11.PubMed
7.
go back to reference Birlutiu V, Birlutiu RM. Endocarditis due to Abiotrophia defectiva, a biofilm-related infection associated with the presence of fixed braces: a case report. Medicine (Baltimore). 2017;96:e8756. Birlutiu V, Birlutiu RM. Endocarditis due to Abiotrophia defectiva, a biofilm-related infection associated with the presence of fixed braces: a case report. Medicine (Baltimore). 2017;96:e8756.
9.
go back to reference Biswas S, Rolain JM. Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture. J Microbiol Methods. 2013;92:14–24.PubMed Biswas S, Rolain JM. Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture. J Microbiol Methods. 2013;92:14–24.PubMed
10.
go back to reference Chang HH, Lu CY, Hsueh PR, Wu MH, Wang JK, Huang LM. Endocarditis caused by Abiotrophia defectiva in children. Pediatr Infect Dis J. 2002;21:697–700.PubMed Chang HH, Lu CY, Hsueh PR, Wu MH, Wang JK, Huang LM. Endocarditis caused by Abiotrophia defectiva in children. Pediatr Infect Dis J. 2002;21:697–700.PubMed
11.
go back to reference Raff GW, Gray BM, Torres A Jr, Hasselman TE. Aortitis in a child with Abiotrophia defectiva endocarditis. Pediatr Infect Dis J. 2004;23:574–6.PubMed Raff GW, Gray BM, Torres A Jr, Hasselman TE. Aortitis in a child with Abiotrophia defectiva endocarditis. Pediatr Infect Dis J. 2004;23:574–6.PubMed
12.
go back to reference Takayama R, Motoyasu M, Seko T, Kuroda K, Yamanaka T, Obe T, Yada T, Konishi T, Fujinaga K, Kondoh C, Mizutani T. A case of isolated tricuspid valve infective endocarditis caused by Abiotrophia defectiva. Int J Cardiol. 2007;118:e3–5.PubMed Takayama R, Motoyasu M, Seko T, Kuroda K, Yamanaka T, Obe T, Yada T, Konishi T, Fujinaga K, Kondoh C, Mizutani T. A case of isolated tricuspid valve infective endocarditis caused by Abiotrophia defectiva. Int J Cardiol. 2007;118:e3–5.PubMed
13.
go back to reference Bhat DP, Nagaraju L, Asmar BI, Aggarwal S. Abiotrophia endocarditis in children with no underlying heart disease: a rare but a virulent organism. Congenit Heart Dis. 2014;9:E116–E12020.PubMed Bhat DP, Nagaraju L, Asmar BI, Aggarwal S. Abiotrophia endocarditis in children with no underlying heart disease: a rare but a virulent organism. Congenit Heart Dis. 2014;9:E116–E12020.PubMed
14.
go back to reference Rudrappa M, Kokatnur L. Infective endocarditis due to Abiotrophia defectiva and its feared complications in an immunocompetent person: rare, but real. J Glob Infect Dis. 2017;9:79–81.PubMedPubMedCentral Rudrappa M, Kokatnur L. Infective endocarditis due to Abiotrophia defectiva and its feared complications in an immunocompetent person: rare, but real. J Glob Infect Dis. 2017;9:79–81.PubMedPubMedCentral
15.
go back to reference Lin YT, Hsieh KS, Chen YS, Huang IF, Cheng MF. Infective endocarditis in children without underlying heart disease. J Microbiol Immunol Infect. 2013;46:121–8.PubMed Lin YT, Hsieh KS, Chen YS, Huang IF, Cheng MF. Infective endocarditis in children without underlying heart disease. J Microbiol Immunol Infect. 2013;46:121–8.PubMed
16.
go back to reference Marom D, Levy I, Gutwein O, Birk E, Ashkenazi S. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J. 2011;30:585–8.PubMed Marom D, Levy I, Gutwein O, Birk E, Ashkenazi S. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J. 2011;30:585–8.PubMed
17.
go back to reference Steinberger J, Moller JH, Berry JM, Sinaiko AR. Echocardiographic diagnosis of heart disease in apparently healthy adolescents. Pediatrics. 2000;105:815–8.PubMed Steinberger J, Moller JH, Berry JM, Sinaiko AR. Echocardiographic diagnosis of heart disease in apparently healthy adolescents. Pediatrics. 2000;105:815–8.PubMed
18.
go back to reference Marom D, Ashkenazi S, Samra Z, Birk E. Infective endocarditis in previously healthy children with structurally normal hearts. Pediatr Cardiol. 2013;34:1415–21.PubMed Marom D, Ashkenazi S, Samra Z, Birk E. Infective endocarditis in previously healthy children with structurally normal hearts. Pediatr Cardiol. 2013;34:1415–21.PubMed
19.
go back to reference Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL. ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.PubMed Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL. ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.PubMed
20.
go back to reference CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. CLSI guideline M45. 3rd ed. Philadelphia: Clinical and Laboratory Standards Institute; 2016. CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. CLSI guideline M45. 3rd ed. Philadelphia: Clinical and Laboratory Standards Institute; 2016.
Metadata
Title
Abiotrophia defectiva as a cause of infective endocarditis with embolic complications in children
Authors
Seung Ha Song
Bin Ahn
Eun Hwa Choi
Seung-Pyo Lee
Eun Young Cho
Eun Jung Bae
Sang Yun Lee
Mi Kyoung Song
Woong Han Kim
Geena Kim
Taek Soo Kim
Mi Seon Han
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01454-z

Other articles of this Issue 5/2020

Infection 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.